Adverse effects of drug therapy in Parkinson disease
Gehlen, W.
Medizinische Monatsschrift für Pharmazeuten 3(4): 104-110
1980
ISSN/ISBN: 0342-9601 PMID: 7464667 Document Number: 163074
Document emailed within 1 workday
Related Documents
Bermejo, F.; Martínez, P.; de Yébenes, J.G. 1986: Parkinson disease, adverse effects of chronic levodopa therapy and drug holidays Archivos de Neurobiologia 49(5): 300-302Klein, U.; Klein, M.; Sturm, H.; Rothenbühler, M.; Huber, R.; Stucki, P.; Gikalov, I.; Keller, M.; Hoigné 1974: Incidence of adverse effects of drug therapy as a function of age, sex and length of hospitalization Schweizerische Medizinische Wochenschrift 104(50): 1892-1893
Reust, C.E. 2011: Common adverse effects of antiretroviral therapy for HIV disease American Family Physician 83(12): 1443-1451
Hernádi, Z.; Juhász, B.; Póka, R.; Mahunka, I.; Lampé, L. 1987: Analysis of the effectiveness and adverse effects of the drug combinations CAP and CEP in the therapy of patients in the advanced stages of ovarian cancer Orvosi Hetilap 128(47): 2457-2461
Gram, L.F. 1977: Adverse effects during treatment with beta receptor blockaders. Report from the Adverse Drug Reaction Committee 1968-1976 Ugeskrift for Laeger 139(35): 2065-2068
Zaka-Ur-Rehman, Z.; Jamshaid, M.; Chaudhry, A. 2008: Clinical evaluation and monitoring of adverse effects for fixed multidose combination against single drug therapy in pulmonary tuberculosis patients Pakistan Journal of Pharmaceutical Sciences 21(2): 185-194
1979: Adverse Drug Reactions Advisory Committee. Peyronie's disease. A complication in therapy with beta-adrenoreceptor blocking drugs? Medical Journal of Australia 2(8): 432
Paulsen, O.; Nilsson, L.M.; Sellin, M.; Osterlind, A.; Lundgren, M.; Fahlesson, P. 1983: Adverse effects and zimelidine therapy. Headache, muscle pain and liver involvement--a new disease entity in zimelidine therapy Lakartidningen 80(1-2): 31-32
Jaźwińska-Tarnawska, E.; Wiela-Hojeńska, A.; Wolańczyk-Medrala, A.; Patkowski, J.; Nittner-Marszalska, M.; Głowacka, K. 2012: Monitoring of NSAIDs adverse effects based on spontaneous reports from Wrocław regional adverse drug reactions monitoring center Acta Poloniae Pharmaceutica 69(5): 979-984
Qi, X.-J.; Wang, S. 2011: Effects of penetration therapy with scalp electroacupuncture on gene expressions of nerve growth factors in substantia nigra of rats with Parkinson's disease Zhongguo Zhen Jiu 31(5): 435-440
Muenter, M.D.; Tyce, G.M. 1971: L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects Mayo Clinic Proceedings 46(4): 231-239
Christiani, K.; Möller, W.D. 1973: Drug therapy of Parkinson's syndrome. Clinical long-term study using L-dopa and the drug conbination L-dopa-decarboxylase inhibitor Münchener Medizinische Wochenschrift 115(16): 711-713
Völler, G.W. 1979: Parkinson syndrome--a contribution on current drug therapy Medizinische Monatsschrift für Pharmazeuten 2(2): 33-40
Zamir, C.; Qivity, S.; Heldenberg, D.; Topilsky, M. 1990: Adverse drug effects in bronchial asthma Harefuah 119(11): 392-396
Yang, Y-Yin.; Dong, Z.; Xia, Y-Peng. 2012: Discussion on adverse reactions monitoring modes of drug manufacturers under new measures for administration of adverse drug reaction report and monitoring Zhongguo Zhong Yao Za Zhi 37(21): 3329-3333
Böhm, C.; Christl, H.L.; Wald, G. 1982: Drug therapy of coronary heart disease. Comparative effects of nifedipine and isosorbide dinitrate Die Medizinische Welt 33(36): 1242-1244
Morrissey, J. 1995: Study shows big picture on adverse drug effects Modern Healthcare 25(30): 76 78
Otero López, M.J.; Bajo Bajo, A.; Maderuelo Fernández, J.A.; Domínguez-Gil Hurlé, A. 1999: Preventable adverse drug effects at an emergency department Revista Clinica Espanola 199(12): 796-805
Forfang, K.; Lippestad, C.T. 1971: Adverse effects of lidocaine as an anti-arrhythmic drug Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 91(10): 710-713
Yoshikawa, T.T.; Nagami, P.H. 1982: Adverse drug reactions in TB therapy: risks and recommendations Geriatrics 37(7): 61-68